Table 1.
Baseline data of patients
| Parameters | Mean (SD) | P | |
|---|---|---|---|
| Fenugreek | Placebo | ||
| Sex | |||
| Male (N) | 13 | 9 | |
| Female (N) | 0 | 2 | |
| Age | 39.08 (11.00) | 39.55 (8.70) | 0.910* |
| BMI | 29.16 (3.92) | 28.38 (4.59) | 0.661* |
| Weight | 88.54 (11.90) | 80.41 (16.61) | 0.177* |
| Waist to hip ratio | 1.05 (0.21) | 0.96 (0.06) | 0.179* |
| Alanine aminotransferase | 57.00 (17.18) | 60.64 (24.90) | 0.677* |
| AST | 34.38 (7.37) | 37.00 (11.44) | 0.506* |
| ALK | 221.08 (42.14) | 248.64 (75.30) | 0.297* |
| Albumin | 4.72 (0.40) | 4.67 (0.34) | 0.783* |
| FBS | 90.31 (12.95) | 90.00 (14.04) | 0.839# |
| Triglyceride | 167.85 (71.36) | 173.82 (88.13) | 0.856* |
| Total cholesterol | 188.92 (26.30) | 174.73 (43.90) | 0.338* |
| LDL | 113.23 (24.93) | 100.27 (33.93) | 0.293* |
| HDL | 42.85 (8.91) | 46.27 (11.28) | 0.414* |
| Uric acid | 5.45 (1.49) | 4.49 (1.21) | 0.100* |
| Creatinine | 0.96 (0.16) | 0.92 (0.13) | 0.450# |
| Hemoglobin | 15.20 (1.32) | 15.51 (1.36) | 0.578* |
| White blood cells | 6.48 (1.41) | 6.86 (1.60) | 0.543* |
| Platelet | 216.85 (64.16) | 241.27 (35.29) | 0.192# |
| Liver stiffness measure | 5.57 (1.16) | 5.32 (1.89) | 0.708* |
| CAP score | 314.62 (36.11) | 286.56 (54.04) | 0.158* |
| Steatosis percent | 71.08 (20.63) | 50.67 (32.69) | 0.122* |
*Independent samples t-test, #Mann-Whitney U-test. AST=Aspartate transaminase, ALK=Alkaline phosphatase, FBS=Fasting blood sugar, LDL=Low-density lipoprotein, HDL=High-density lipoprotein, CAP=Controlled attenuation parameter, BMI=Body mass index, SD=Standard deviation